Study of Avelumab-M3814 Combinations
Clinical trial NCT03724890 · COMPLETED
Trial details
- NCT number
- NCT03724890
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-27
- Primary completion
- 2021-09-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.